Pfizer Agrees to Share Incremental Overseas Drug Revenue With HHS
MT Newswires Live
Sep 21
Pfizer (PFE) will share a portion of increased revenue from higher drug prices abroad with the US Department of Health and Human Services under a contract tied to the Trump administration's "most favored nation" pricing policy, according to newly released documents obtained by Public Citizen.
The deal with Pfizer runs through Jan. 20, 2029, the consumer advocacy group said.
The contract says HHS will use the funds to lower costs for US patients and taxpayers, without specifying more details.
Pfizer and the White House did not immediately respond to MT Newswires' request for comment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.